Risperidone and corrected QT-interval Prolongation in surface electrocardiogram

Pakistan Journal of Biological Sciences

Volumn 15, Issue 10, 2012, Pages 496-500

  Ranjbar, F ^a   Akbarzadeh, F ^b   Ahmadi, N M ^b   Abbasnejhad, M ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antipsychotic; Antipsychotic dmgs; Arrhythmia; Atypical; Electrocardogram; Risperidone; Side effects

Indexed keywords

EID: 84867538235     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2012.496.500     Document Type: Article

References (23)

1. Bazett, H.C., 1920. The time relations of the blood-pressure changes after excision of the adrenal glands, with some observations on blood volume changes. J. Physiol., 53: 320-339.
2. Benoit, S.R., A.B. Mendelsohn, P. Nourjah, J.A. Staffa and D.J. Graham, 2005. Risk factors for prolonged QTc among US adults: Third national health and nutrition examination survey. Eur. J. Cardiovasc. Prev. Rehab., 12: 363-368.
3. Bernardi, M., S. Calandra, A. Colantoni, F. Trevisani and M.L. Raimondo et al., 1998. Q-T interval prolongation in cirrhosis: Prevalence, relationship with severity and etiology of the disease and possible pathogenetic factors. Hepatology, 27: 28-34.
4. Brown, D.W., W.H. Giles, K.J. Greenlund, R. Valdez and J.B. Croft, 2001. Impaired fasting glucose, diabetes mellitus and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the third national health and nutrition examination survey. J. Cardiovasc. Risk, 8: 227-233.
5. Campbell, M., P.I. Young, D.N. Bateman, J.M. Smith and S.H. Thomas, 1999. The use of atypical antipsychotics in the management of schizophrenia. Br. J. Clin. Pharm., 47: 13-22.
6. Drolet, B., T. Yang, P. Daleau, D.M. Roden and J. Turgeon, 2003. Risperidone prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current. J. Cardiovasc. Pharm., 41: 934-937.
7. Giunti, S., G. Bruno, E. Lillaz, G. Gruden and V. Lolli et al., 2007. Incidence and risk factors of prolonged QTc interval in type 1 diabetes: The EURODIAB Prospective Complications Study. Diabetes Care, 30: 2057-2063.
8. Goyal, R.S. and S.B. Goyal, 2003. Symptomatic bradyarrhythmia secondary to risperidone. Am. J. Psychiatry, 160: 2243-2244.
9. Grandinetti, A., S. Seifried, J. Mor, H.K. Chang and A.G. Theriault, 2005. Prevalence and risk factors for prolonged QTc in a multiethnic cohort in rural Hawaii. Clin. Biochem., 38: 116-122.
10. Hosseini, S.H. and A.K. Polonowita, 2009. Priapism associated with olanzapine. Pak. J. Biol. Sci., 12: 198-200.
11. Huq, F., 2007. Molecular modelling analysis of the antioxidant activity of probucol. Asian J. Biochem., 2: 354-358.
12. Idonije, O.B., O.O. Festus, U. Akpamu, O. Okhiai, O.I. Iribhogbe and G.B.S. Iyalomhe, 2012. A comparative study of the effects of clozapine and risperidone monotherapy on lipid profile in nigerian patients with schizophrenia. Inter. J. Pharm., 8: 169-176.
13. Jervell, A. and F. Lange-Nielsen, 1957. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am. Heart J., 54: 59-68.
14. Kilic, F.S., B. Kaigisiz, C. Baydemir and K. Erol, 2012. The effects of Ziprasidone on motor functions in experimental parkinson model in mice. Int. J. Pharmacol. (In Press).
15. Malik, M. and A.J. Camm, 2001. Evaluation of drug-induced QT interval prolongation: Implications for drug approval and labelling. Drug Saf., 24: 323-351.
16. Morita, H., J. Wuand D.P. Zipes, 2008. The QT syndromes: Long and short. Lancet, 372: 750-763.
17. Potkin, S.G., A.R. Saha, M.J. Kujawa, W.H. Carson and M. Ali et al., 2003. Aripiprazole, an antipsychotic with a novel mechanism of action and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Arch. Gen. Psychiatry, 60: 681-690.
18. Ravina, T., P. Ravina and J. Gutierrez, 2007. Acquired long QT syndrome: Risperidone-facilitated triggered activity and Torsades de Pointes during complete AV block. I. Int. J. Cardiol., 116: 416-420.
19. Reinsch, N., C. Buhr, P. Krings, H. Kaelsch and K. Neuhaus, et al., 2009. Prevalence and risk factors of prolonged QTc interval in HIV-infected patients: Results of the HIV-HEART study. HIV Clin. Trials, 10: 261-268.
20. Suzuki, Y., N. Fukui, J. Watanabe, S. Ono and T. Sugai et al., 2012. QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone. Hum. Psycho. Pharm., 27: 39-42.
21. Taylor, D.M., 2003. Antipsychotics and QT prolongation. Acta Psychiatr. Scand., 107: 85-95.
22. Tran, K.T., P.T. Golden and N.J. Jacob, 2004. Bradycardia at low doses of risperidone. Am. J. Psychiatry, 161: 2325-2326.
23. Welch, R. and P. Chue, 2000. Antipsychotic agents and QT changes. J. Psychiatry Neurosci., 25: 154-160.